Searched for
SUMITOMO PHARMA
Ahead of Market: 10 things that will decide stock market action on MondayIndian stock markets surged on Friday, with Sensex and Nifty posting gains exceeding 0.3%. This upward trend was fueled by a calmer Middle ...- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- Positive Breakout: These 11 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
- Global Markets | Japan's Nikkei climbs as AI optimism outweighs Mideast concernsJapanese stocks surged Monday, nearing a historic peak, fueled by booming AI sector enthusiasm that overshadowed Middle East tensions. Majo...
- Japan approves stem-cell treatment for Parkinson's in world firstPharmaceutical company Sumitomo Pharma said it received the green light for the manufacture and sale of Amchepry, its Parkinson's disease t...
- Global Markets: Japanese shares dip as soft data, post-election lull cap movesJapanese shares drifted lower on Monday as weaker-than-expected economic data and a post-election lull capped moves.
- TrumpRx: Japanese drugmakers slump after Trump unveils discount drug websiteShares of Japanese pharmaceutical companies fell sharply in early Tokyo trading after the launch of TrumpRx, a U.S. website offering discou...
- Japan's Nikkei gauge trims 2025 surge as techs take a breatherJapan's Nikkei index saw a slight dip on Tuesday, with tech stocks leading the decline. Despite this, the Nikkei is on track for a signific...
- Japan's Topix posts record-high close despite US tariffs on pharmaJapan's broad Topix index closed at an all-time high on Friday, despite pressure from pharmaceutical shares following new tariffs on the se...
- Japan's Topix hits record high despite US tariffs on pharmaJapan's Topix index reached a record high on Friday. This happened despite pharmaceutical shares facing pressure. The Nikkei index, however...
- Japan's Nikkei treads water as central bank meetings, tariff deadline loomNikkei remained stable as investors are cautious. Policy announcements from the Federal Reserve and Bank of Japan are expected. Trump's tra...
- Japan's Nikkei inches higher amid weaker yen, pharma extends rallyJapan's Nikkei share average rose in early trade on Friday, with pharma shares rallying for a second session, although gains were limited d...
- Japanese shares gain tracking US futures; tech and pharma stocks boostThe Nikkei share average gained 0.67 per cent at 28.822.29, after declining 0.2 per cent earlier, while the broader Topix inched up 0.29 pe...
- Nikkei rebounds as Fed's shift calms nerves; gains 3.8% in JanuaryFor the month, the Nikkei gained 3.8 per cent, after diving 10.5 per cent last month.
- Sumitomo Chemical to take majority stake in Excel Crop CarePursuant to the purchase of stakes from promoter and certain public shareholders, Sumitomo will make offer to the public to purchase up to ...
- Excel Crop Care will immensely benefit from Sumitomo deal: Dipesh Shroff, MD"The research products of Sumitomo and our manufacturing capability make a very good combination," says the managing director of the compan...
- Reliance Capital rallies 3% on stake sale reports to Sumitomo MitsuiThe deal signals bullishness among Japanese cos that seem keen to invest in sectors ranging from pharma to financial services in Asia's 3rd...
- Dr Reddy's Laboratories will infringe on Lunesta's patent: US court of appealThe United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the paten...
- Dr Reddy's under pressure on losing appeal for LunestaDr Reddy's Laboratories were witnessing profit booking on reports that the company has lost a patent case for generic version of Lunesta.
- Lupin settles litigation over Lunesta with Japanese firmDrug firm Lupin on Monday said it has settled ongoing litigation over Lunesta tablets, used in treating insomnia, with Japan-based Dainippo...
Load More
